Georgiy V Bobashev1, William A Zule. 1. RTI International, Statistics and Epidemiology, 3040 Cornwallis Road, Research Triangle Park, NC 27709, USA. bobashev@rti.org
Abstract
AIMS: To illustrate the impact of different proportions of injecting drug users (IDUs) sharing high dead-space syringes (HDSS) or low dead-space syringes (LDSS) on the probability of human immunodeficiency virus (HIV) transmission; and thus the impact on injection-related HIV prevalence and incidence. DESIGN: A stochastic mathematical model was used to evaluate the impact of HDSS use in high- and low-risk IDU populations. Model parameters were obtained from peer-reviewed publications. Analytical solutions of a simplified deterministic model were obtained to explain the effect of HDSS on HIV endemic states. FINDINGS: Simulation analysis shows that the HIV epidemic could be sustained even when a small percentage of sharing (10%) involved HDSS. The effect is much stronger in high-risk compared with low-risk populations. Steady state HIV prevalence increases with the proportion of HDSS, and for high- and low-risk populations reaches around 80% and 20%, respectively. For low-risk populations, the use of LDSS could result in the virtual elimination of HIV. These results are dependent upon an evidence-supported assumption of a significant difference in HIV transmission risk associated with HDSS versus LDSS. CONCLUSIONS: Our models suggest that injection-related HIV epidemics may not occur when most (e.g. 95% or more) IDUs use LDSS. While these results are based on indirect risk measures and a number of simplifying assumptions, the effect of blood retained in high dead-space syringes on HIV prevalence seems to be very strong, even using relatively conservative assumptions. The findings have potential implications for needle exchange programs and the types of syringes produced and distributed world-wide.
AIMS: To illustrate the impact of different proportions of injecting drug users (IDUs) sharing high dead-space syringes (HDSS) or low dead-space syringes (LDSS) on the probability of human immunodeficiency virus (HIV) transmission; and thus the impact on injection-related HIV prevalence and incidence. DESIGN: A stochastic mathematical model was used to evaluate the impact of HDSS use in high- and low-risk IDU populations. Model parameters were obtained from peer-reviewed publications. Analytical solutions of a simplified deterministic model were obtained to explain the effect of HDSS on HIV endemic states. FINDINGS: Simulation analysis shows that the HIV epidemic could be sustained even when a small percentage of sharing (10%) involved HDSS. The effect is much stronger in high-risk compared with low-risk populations. Steady state HIV prevalence increases with the proportion of HDSS, and for high- and low-risk populations reaches around 80% and 20%, respectively. For low-risk populations, the use of LDSS could result in the virtual elimination of HIV. These results are dependent upon an evidence-supported assumption of a significant difference in HIV transmission risk associated with HDSS versus LDSS. CONCLUSIONS: Our models suggest that injection-related HIV epidemics may not occur when most (e.g. 95% or more) IDUs use LDSS. While these results are based on indirect risk measures and a number of simplifying assumptions, the effect of blood retained in high dead-space syringes on HIV prevalence seems to be very strong, even using relatively conservative assumptions. The findings have potential implications for needle exchange programs and the types of syringes produced and distributed world-wide.
Authors: Daniel Ciccarone; George Jay Unick; Jenny K Cohen; Sarah G Mars; Daniel Rosenblum Journal: Drug Alcohol Depend Date: 2016-04-14 Impact factor: 4.492
Authors: Claudia Rafful; William Zule; Patricia E González-Zúñiga; Dan Werb; María Elena Medina-Mora; Carlos Magis-Rodriguez; Steffanie A Strathdee Journal: Am J Drug Alcohol Abuse Date: 2015-02-19 Impact factor: 3.829
Authors: Christine U Oramasionwu; Terence L Johnson; William A Zule; Jessica Carda-Auten; Carol E Golin Journal: Am J Public Health Date: 2015-04-16 Impact factor: 9.308
Authors: Joanna M Kesten; Rachel Ayres; Jane Neale; Jody Clark; Peter Vickerman; Matthew Hickman; Sabi Redwood Journal: Int J Drug Policy Date: 2016-10-24
Authors: William A Zule; Alisher Latypov; David Otiashvili; Irma Kirtadze; Umedjon Ibragimov; Georgiy V Bobashev Journal: Harm Reduct J Date: 2015-10-16
Authors: William A Zule; Poonam G Pande; David Otiashvili; Georgiy V Bobashev; Samuel R Friedman; V Anna Gyarmathy; Don C Des Jarlais Journal: Harm Reduct J Date: 2018-01-15
Authors: Steffanie A Strathdee; Jaime Arredondo; Teresita Rocha; Daniela Abramovitz; Maria Luisa Rolon; Efrain Patiño Mandujano; Maria Gudelia Rangel; Horcasitas Omar Olivarria; Tommi Gaines; Thomas L Patterson; Leo Beletsky Journal: BMJ Open Date: 2015-08-10 Impact factor: 2.692